northernkush
Member
All the newfs are in fort mcmurray. Newfoundlands second biggest city!
-
Happy Birthday ICMag! Been 20 years since Gypsy Nirvana created the forum! We are celebrating with a 4/20 Giveaway and by launching a new Patreon tier called "420club". You can read more here.
-
Important notice: ICMag's T.O.U. has been updated. Please review it here. For your convenience, it is also available in the main forum menu, under 'Quick Links"!
MMPR- meet the players
- Thread starter Chimera
- Start date
- Status
northernkush
Member
Yes by! Where you to, what r you at???
VanCitysFinest
Active member
Buds Bundy
Member
How do these companies plan on competing with the 60+ other competitors and the underground?
I know someone who got theirs, they are listed and they plan on lots of exporting. Already has a contract with another country for 2Klb. Sorry cant reveal the names atm.
I know someone who got theirs, they are listed and they plan on lots of exporting. Already has a contract with another country for 2Klb. Sorry cant reveal the names atm.
tomjonesthe3rd
Member
Interesting. Not too many countries to export to at this point, but long term that is definitely what many LP's will likely look at. I'm curious what country your secret LP (one of only 7) is looking at.
tomjonesthe3rd
Member
I'm heard abattis has given up on their LP status and just want to market products to dispensaries and LP's.
they get smart and hire me to lay out there spaces with seeds, systems, nutes and recipes
med-man
holland, isreal, uruguay, u.s.
cali is expecting a shitty grow season. and with states lining up for full legalization. people will be busy with sales
med-man
VanCitysFinest
Active member
not too sure about this exporting thing... that seems like 5+ years away from being tangible
J
j0yr1d3
So let's see, Peace Naturals are sold out of all but 2 strains, Mettrum currently only offers 2 strains, nobody in their right mind will sign up for Cannimed or Bedrocan based on irradiating product alone, Canna Farms won't be ready til May, Thunderbird won't be ready til July, Tweed claims to have 300+ patients already. Already talk of supply and access issues here in Canada and people are looking at an export market? This whole new system seems nonsensical to me. I don't see how all these producers are going to survive off poor patients especially when the product being offered seems to be mostly a joke or not even available. Interesting times ahead.
Buds Bundy
Member
300 patients means nothing, this website probably has 30,000 signups past the normal regular users. if those people are buying 5 grams per day at $25 that's thats $750 per month in medication. Ok well I can tell you that even people making $3500-5000 per month after taxes no way in hell would be spending that much money every month unless you are single, no debt and just plain careless with your money hence why people originally wanted to grow because with a $2000 set up you can grow all you need for aprox. $200 per lb that's if you buy all new mediums/food/babies/every crop.
As for the exporting his came from a customer who got their license. Their main goal is exporting, hell you got 34mil people (possibly 20K regular buyers) vs the world and building up their stock market price eventually.
The up and coming system is so fucking retarded you really got to wonder who set this up and why. Is it for eventual legalization? Who the hell knows... Makes you wonder about the "Marihuana" mandatory sentences for production. There's only one reason that law was introduced in this day and age (especaily with the USA!!! states next door lagalizing MJ) was to protect the licensed producers BUT the business model for Canada is flawed if there's going to be 100+ licensed producers. Shit so far there are 64 companies that got the letter of intent saying they are guaranteed a license if the final building site inspections pass.
honestly guys
once the u.s., isreal and s america actually get too see and smoke green weed, with crystals. canada will not even come close to supply in export, let alone local markets. people think prices will dip, i doubt it.
med-man
once the u.s., isreal and s america actually get too see and smoke green weed, with crystals. canada will not even come close to supply in export, let alone local markets. people think prices will dip, i doubt it.
med-man
J
j0yr1d3
I feel like I'm stuck in limbo right now with all these new regulations and uncertainties. I only recently received my ATP in December, I've basically been getting off "friends of friends" since I refuse to use the HC supply. I'm wary of signing up with a compassion club as there doesn't seem to be much "compassion" with their pricing. The available LP's right now are kind of a joke with inferior product and low supply. Basically I'm just waiting to see what happens and how accessible my medicine will actually become under these new regulations. Also does anyone know what happens during the patient registration phase? My understanding is it can take up to 6 weeks to register as a patient with an LP. What are you supposed to do in that time? Does your ATP become invalid the minute it's in the mail? What if I send in my ATP and get arrested during the time it's in the mail? I have no proof to show during this limbo period. Just some things I've thought about.
J
j0yr1d3
Came across this earlier...
http://www.newswire.ca/en/story/1305533/the-hydropothecary-corporation-thc-introduces-luxury-medical-marijuana-products
Prices start at $18/g? Are we paying prison prices now? They hoping there's a few millionaire patients out there that are gullible enough to believe any marijuana is worth $18 a gram?
http://www.newswire.ca/en/story/1305533/the-hydropothecary-corporation-thc-introduces-luxury-medical-marijuana-products
Prices start at $18/g? Are we paying prison prices now? They hoping there's a few millionaire patients out there that are gullible enough to believe any marijuana is worth $18 a gram?
B
Blused
That is Pathetic, these guys are looking at Cali and such. Cali topshelf 15 a g all day, (Sad)
Sounds like a scam . The are only catering to under 1k people . Sounds like a way to create money and clean money in organized crime . All them biker license in one building
http://www.sacbee.com/2014/02/13/6155342/medijean-provides-a-glimpse-into.html
MediJean Provides a Glimpse into their Medical Marijuana Research
By MediJean
Published: Thursday, Feb. 13, 2014 - 10:17 am
VANCOUVER, Feb. 13, 2014 -- /CNW/ - MediJean, a medical marijuana company who has been given approval by Health Canada to grow medical cannabis for R&D purposes, today provided insight into the research they are working on that will help patients and doctors better understand this medicine.
"The R&D we are conducting on medical marijuana is groundbreaking," said Charles Scott, director of research and development at MediJean. "Many believe that 'CBD' levels are the sole determinant for producing a medical cannabis without psychoactive effects; however, this belief is false. There are many components that must be taken into account, such as terpene levels, the strain of cannabis itself and the breeding techniques used in producing a strain or cross-bred strain."
MediJean has developed a technique that allows them to cross-breed strains of cannabis to create delicate chemovars that have high levels of Cannabidiol (CBD) and balanced levels of Tetrahydrocannabinol (THC), plus an elevated terpene content. It is generally accepted that CBD acts as a modulator of THC, reducing the psychoactive effects (the high) associated with THC when present in a 1:1 or greater ratio. However, MediJean has learned that there is an interrelationship - a catalyst - between terpenes and THC that alters its overall effect. For example, the most common terpene - linalool - used in conjunction with other terpenes in various ratios alter the medical effect of medical cannabis and allow MediJean to create strains that can target specific conditions that people suffer from. The knowledge of this synergistic effect between THC and terpenes enables the researchers at MediJean to draw these conclusions.
MediJean's researchers understand that THC is a vital component to the healing compounds of medical marijuana. "THC has been shown to have ten times the analgesic effect of acetylsalicylic acid (ASA) and twice that of hydrocortisone steroids; both of which are a commonly accepted method of treatment by doctors. However, THC also serves as the main element that brings on the onset of the "high" effects, which until now has been a side effect of medical cannabis when treating certain conditions. Through a complex understanding of how active compounds interact and the resulting development of chemovars with effective ratios for given conditions, we have been able to discover a formula that will reduce or modulate the high of THC and in certain cases totally eliminate THC but maintain the healing properties to counter certain conditions and or make the patient as comfortable as possible without the toxic side effects of alternative treatments," said Scott.
"Breakthroughs such as this will allow patients who may have concerns about the potential psychoactive effects be more comfortable with the medicine," said Jean Chiasson, chief executive officer at MediJean. "The more we are able to gain a greater understanding of the interactions between all the active compounds, the more pinpoint our chemovar development will become. It is our understanding of the delicate science surrounding CBD's, THC, and terpenes that make us thought leaders in the medical marijuana arena today, and it will be our commitment to ongoing research that will solidify our role as global leaders into the future."
MediJean believes the health solutions this medicine can have are endless. However, they caution patients to do their research before choosing a provider. "Patients must look to a provider who is continuing to raise the bar in this field, one that isn't satisfied with just offering a few strains," said Chiasson. "Research and quality are the key measures. It is a matter of ensuring that proper grow techniques are followed and that proper ratio balances of all the elements of the medicine are understood and adhered to. This is what we are doing at MediJean and it is what sets us apart."
MediJean is leading the rebirth of medical marijuana through a laser focus on research, quality and patient experience by implementing best practices here and around the world. Doctors and nurse practitioners will understand and safely prescribe it within a clinical framework, patients will have access to clean and affordable medicine, and research partners will help the company expand the frontiers of medical marijuana in the years ahead. To learn more about MediJean and their plan to lead this new industry visit www.medijean.com and signup for their regular updates. Doctors and nurse practitioners are encouraged to contact MediJean to arrange a discussion of their practices and/or a tour of their facility.
SOURCE MediJean
MediJean Provides a Glimpse into their Medical Marijuana Research
By MediJean
Published: Thursday, Feb. 13, 2014 - 10:17 am
VANCOUVER, Feb. 13, 2014 -- /CNW/ - MediJean, a medical marijuana company who has been given approval by Health Canada to grow medical cannabis for R&D purposes, today provided insight into the research they are working on that will help patients and doctors better understand this medicine.
"The R&D we are conducting on medical marijuana is groundbreaking," said Charles Scott, director of research and development at MediJean. "Many believe that 'CBD' levels are the sole determinant for producing a medical cannabis without psychoactive effects; however, this belief is false. There are many components that must be taken into account, such as terpene levels, the strain of cannabis itself and the breeding techniques used in producing a strain or cross-bred strain."
MediJean has developed a technique that allows them to cross-breed strains of cannabis to create delicate chemovars that have high levels of Cannabidiol (CBD) and balanced levels of Tetrahydrocannabinol (THC), plus an elevated terpene content. It is generally accepted that CBD acts as a modulator of THC, reducing the psychoactive effects (the high) associated with THC when present in a 1:1 or greater ratio. However, MediJean has learned that there is an interrelationship - a catalyst - between terpenes and THC that alters its overall effect. For example, the most common terpene - linalool - used in conjunction with other terpenes in various ratios alter the medical effect of medical cannabis and allow MediJean to create strains that can target specific conditions that people suffer from. The knowledge of this synergistic effect between THC and terpenes enables the researchers at MediJean to draw these conclusions.
MediJean's researchers understand that THC is a vital component to the healing compounds of medical marijuana. "THC has been shown to have ten times the analgesic effect of acetylsalicylic acid (ASA) and twice that of hydrocortisone steroids; both of which are a commonly accepted method of treatment by doctors. However, THC also serves as the main element that brings on the onset of the "high" effects, which until now has been a side effect of medical cannabis when treating certain conditions. Through a complex understanding of how active compounds interact and the resulting development of chemovars with effective ratios for given conditions, we have been able to discover a formula that will reduce or modulate the high of THC and in certain cases totally eliminate THC but maintain the healing properties to counter certain conditions and or make the patient as comfortable as possible without the toxic side effects of alternative treatments," said Scott.
"Breakthroughs such as this will allow patients who may have concerns about the potential psychoactive effects be more comfortable with the medicine," said Jean Chiasson, chief executive officer at MediJean. "The more we are able to gain a greater understanding of the interactions between all the active compounds, the more pinpoint our chemovar development will become. It is our understanding of the delicate science surrounding CBD's, THC, and terpenes that make us thought leaders in the medical marijuana arena today, and it will be our commitment to ongoing research that will solidify our role as global leaders into the future."
MediJean believes the health solutions this medicine can have are endless. However, they caution patients to do their research before choosing a provider. "Patients must look to a provider who is continuing to raise the bar in this field, one that isn't satisfied with just offering a few strains," said Chiasson. "Research and quality are the key measures. It is a matter of ensuring that proper grow techniques are followed and that proper ratio balances of all the elements of the medicine are understood and adhered to. This is what we are doing at MediJean and it is what sets us apart."
MediJean is leading the rebirth of medical marijuana through a laser focus on research, quality and patient experience by implementing best practices here and around the world. Doctors and nurse practitioners will understand and safely prescribe it within a clinical framework, patients will have access to clean and affordable medicine, and research partners will help the company expand the frontiers of medical marijuana in the years ahead. To learn more about MediJean and their plan to lead this new industry visit www.medijean.com and signup for their regular updates. Doctors and nurse practitioners are encouraged to contact MediJean to arrange a discussion of their practices and/or a tour of their facility.
SOURCE MediJean
- Status
